Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
IMMUNOTHERAPY AND EXPERIMENTAL APPROACHES FOR METASTATIC MELANOMA
Autore:
ATKINS MB;
Indirizzi:
BETH ISRAEL DEACONESS MED CTR,DIV HEMATOL ONCOL,MELANOMA & BIOL THERAPY PROGRAMS BOSTON MA 02215 HARVARD UNIV,SCH MED,DEPT MED BOSTON MA 00000
Titolo Testata:
Hematology/oncology clinics of North America
fascicolo: 4, volume: 12, anno: 1998,
pagine: 877 -
SICI:
0889-8588(1998)12:4<877:IAEAFM>2.0.ZU;2-#
Fonte:
ISI
Lingua:
ENG
Soggetto:
TUMOR-INFILTRATING LYMPHOCYTES; HIGH-DOSE INTERLEUKIN-2; CYTOLYTIC T-LYMPHOCYTES; ACTIVATED KILLER CELLS; ANTIBODY-INTERLEUKIN-2 FUSION PROTEINS; RECOMBINANT HUMAN INTERLEUKIN-2; IMMUNOLOGICAL ADJUVANT QS-21; MONOCLONAL-ANTIBODY R24; NECROSIS-FACTOR-ALPHA; ADVANCED RENAL-CANCER;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
149
Recensione:
Indirizzi per estratti:
Citazione:
M.B. Atkins, "IMMUNOTHERAPY AND EXPERIMENTAL APPROACHES FOR METASTATIC MELANOMA", Hematology/oncology clinics of North America, 12(4), 1998, pp. 877

Abstract

This article reviews the clinical investigations involving recombinant cytokines (either alone or in combination with adoptive immunotherapy, toxicity reduction agents, or cytotoxic chemotherapy), vaccines, monoclonal antibodies or antibody conjugates, and gene therapy. These various approaches are reviewed for their current and potential roles incuring metastatic melanoma.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/11/20 alle ore 09:43:44